Sonnet Biotherapeutics Holdings Inc (SONN) — Cash Flow Quality Index

Latest as of March 2024: 1.98x

Sonnet Biotherapeutics Holdings Inc (SONN) has a Cash Flow Quality Index of 1.98x as of March 2024. Operating cash flow of $723.79K exceeds net income of $365.43K, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Sonnet Biotherapeutics Holdings Inc generate cash to assess how effectively this company generates cash.

Cash Flow Quality Index

1.98x

Operating CF / Net Income

Operating Cash Flow

$723.79K

USD

Net Income

$365.43K

USD

Data as of

Mar 2024

Most recent filing

Annual Cash Flow Quality Index for Sonnet Biotherapeutics Holdings Inc (None–None)

Year-by-year earnings quality comparison for Sonnet Biotherapeutics Holdings Inc. For live market cap and the full company financial profile, see SONN market cap.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.